Professional Interests


- Program & Evaluation Design
- Community Capacity Building and Health Education
- Health and Wellness Coaching
- Health Education Design

Work Experience


  • BeWell Commitment to Community (1,000+ volunteer hours), Stanford University Employee Wellness Program (BeWell) (1/1/2019 - 1/1/2022)

    Co-created and led an initiative facilitated the engagement of Stanford University employee community to get better acquainted to the ways that civic engagement is can benefit individual health and community well-being.

    Location

    Stanford University

  • BeWell Workshops (10,000+ participants), Stanford University Employee Wellness (BeWell) (1/1/2008 - 1/1/2019)

    Co-Created Workshops for the Stanford Employee Community through community needs assessments and partnership of leading researchers/instructors in the Stanford community. Topics covered many health related topics such as Sleep, Nutrition, Stress Management, Mindfulness, Community/Civic Engagement, Volunteerism and much more.

    Location

    Stanford University

  • BeWell Launch, Stanford University Employee Wellness Program (BeWell) (1/1/2008 - 1/1/2011)

    Co-created, launched and implemented the Stanford Employee Wellness Program (BeWell) through needs assessment, website design, content creation, community outreach and organizing.

    Location

    STANFORD UNIVERSITY

  • Policy: Tobacco Free Designated in School of Medicine, Stanford University School of Medicine (1/1/2006 - 1/1/2008)

    On the execution and implementation team for the of the prohibition of tobacco in the Stanford University School of Medicine the policy was endorsed by the Executive Committee of the School of Medicine and approved by the Dean and the President. The Vice Provost and Dean of Research and the President approved the inclusion of the James H. Clark Center.

    Location

    STANFORD UNIVERSITY

  • Tobacco Cessation (Individual), Stanford University (1/1/1996 - Present)

    Design and instruct tobacco cessation programs to Stanford University Employees using a long-term coaching approach.

    Location

    STANFORD UNIVERSITY

  • Chronic Disease Self-Management (Group Facilitation), Stanford University Patient Education Research Center (May 20, 1998 - 1/1/2000)

    Location

    Stanford

  • Women's Health Clinical Trials, Stanford University (1/1/2006 - 1/1/2008)

    Location

    Stanford University

  • Statistical Analysis, Stanford University (1/1/2007 - 12/1/2007)

    Lead statical on publication.

    Location

    Stanford University

All Publications


  • Integrating Photovoice and Citizen Science: The Our Voice Initiative in Practice. Health promotion practice Zha, C. C., Jansen, B., Banchoff, A., Fernes, P., Chong, J., Castro, V., Vallez-Kelly, T., Fenton, M., Rogers, J., King, A. C. 2022; 23 (2): 241-249

    Abstract

    Community engagement methods like photovoice have allowed researchers to gather and incorporate the experiences and perspectives of community members in their work but have at times faced challenges regarding systematization, accessibility, and scalability. This practice note describes the Our Voice initiative, one example of a community-based participatory research framework that aims to build on photovoice theories and best practices and address these challenges by incorporating the use of a mobile app as well as elements of participatory action-based citizen science to support community-driven data collection, analysis, and advocacy. We explore the application of the Our Voice method and evaluation of multilevel participant and community outcomes across three different Bay Area, California, communities. In doing so, we hope to provide a potential example for practitioners of other community-based participatory research and photovoice-based models to draw from when working with diverse communities to integrate local perspectives and insights in the generation and implementation of sustainable community health improvements.

    View details for DOI 10.1177/15248399211054784

    View details for PubMedID 35285322

  • A multimodal assessment of tobacco use on a university campus and support for adopting a comprehensive tobacco-free policy. Preventive medicine Wong, S. L., Epperson, A. E., Rogers, J. n., Castro, R. J., Jackler, R. K., Prochaska, J. J. 2020: 106008

    Abstract

    Many college campuses now prohibit tobacco use. At a private U.S. university, the current study assessed cigarette and e-cigarette use and characterized the climate for adopting a comprehensive tobacco-free policy. Data were gathered January-August 2018 via an: environmental scan; cigarette-urn audit; and representative surveys with campus community members. Despite low prevalence of tobacco (0.5%-8%) and e-cigarette use (0.9%-6%) among all groups, campus cigarette clean-up costs exceeded $114,000 for an estimated >1 million butts left on campus annually. A majority of respondents (63% of N = 2218) favored a campus-wide tobacco-free policy, 16% opposed, and 21% abstained. Most respondents endorsed benefits of supporting health (93%), ensuring tobacco-free air to breathe (92%), reducing litter (88%), preventing tobacco use (84%) and fires (83%), and helping tobacco users quit (65%). Identified challenges included policy enforcement (69%) and stigmatization of smoking (57%); 30% viewed a policy as compromising personal freedoms. In a model explaining 35% of variance in policy support, those more likely to favor comprehensive tobacco-free campus policy were Asian respondents; diagnosed with asthma; exposed to secondhand smoke on campus; who viewed campus cigarette butt litter as problematic; and identified health, prevention, and cessation benefits of a tobacco-free campus. Those less likely in favor were students, those who smoke, and those perceiving impingement upon personal freedoms, stigmatization, and broader (slippery slope) implications. Findings indicate low tobacco use prevalence among the campus community, yet a large volume of butt litter and high tobacco clean-up costs. Predictors of policy support can inform campus outreach efforts.

    View details for DOI 10.1016/j.ypmed.2020.106008

    View details for PubMedID 32027917

  • Major depression among adolescent smokers undergoing treatment for nicotine dependence ADDICTIVE BEHAVIORS Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Samuels, D., Schatzberg, A. F. 2004; 29 (8): 1517-1526

    Abstract

    This is the first study to examine the prevalence and effects of major depression (MDD) in a sample of adolescent smokers (N = 211) undergoing treatment for nicotine dependence. We assessed MDD at baseline and end of treatment with the mood disorders portion of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). Eleven percent of participants reported a history of MDD (6% of males and 21% of females). Study variables did not distinguish those with and without a history of MDD. End of treatment abstinence rates and relapse rates were similar in both groups. Two participants (1%), both female, experienced onset of MDD during the treatment. The findings provide further evidence that MDD is a comparatively common disorder among children and adolescents and that clinicians should monitor and be prepared to respond to depression that may emerge during the treatment of nicotine-dependent adolescents.

    View details for DOI 10.1016/j.addbeh.2004.02.029

    View details for Web of Science ID 000224464000002

    View details for PubMedID 15451121

  • Randomized clinical trial of the efficacy of Bupropion combined with nicotine patch in the treatment of adolescent smokers JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., Samuels, D., Levin, S. K., Green, S., Schatzberg, A. F. 2004; 72 (4): 729-735

    Abstract

    Adolescent smokers (N = 211) were randomized to 1 of 2 groups: (a) nicotine patch plus bupropion SR (sustained release; 150 mg per day) or (b) nicotine patch plus placebo. Group skills training sessions were conducted each week by research staff. Abstinence rates at Weeks 10 and 26 were as follows: (a) patch plus bupropion, 23% and 8%, (b) patch plus placebo, 28% and 7%. Despite the lack of a treatment effect, a large majority of adolescents in both treatment groups reduced their consumption to a few cigarettes per day or less and maintained this reduction over time. Similarly, an examination of survival curves revealed that by the end of treatment many had managed to avoid a return to daily smoking. These findings are encouraging and suggest new avenues for research. For example, treatments of the kind examined in this report, augmented by extended maintenance therapies, may yield higher long-term success rates.

    View details for DOI 10.1037/0022-006X.72.4.729

    View details for Web of Science ID 000222924600020

    View details for PubMedID 15301658